# Intermittent Hypoxia 2: Cardiovascular and Metabolism

> **NCT02058823** · PHASE4 · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 12 (actual)

## Conditions studied

- Hypoxia
- Sleep Apnea
- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Placebo
- **DRUG:** Placebo
- **DRUG:** Valsartan
- **DRUG:** Amlodipine

## Key facts

- **NCT ID:** NCT02058823
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08-07
- **Primary completion:** 2014-07-17
- **Final completion:** 2017-03-16
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** budget constraints
- **Last updated:** 2018-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02058823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02058823, "Intermittent Hypoxia 2: Cardiovascular and Metabolism". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02058823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*